Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017651 · ClinicalTrials.gov registry record · Phase 1
An Evaluation of Omega-3 Fatty Acid
A Phase 1 study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT03017651 is a Phase 1 study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 30 participants.
The verdict
NCT03017651, a Phase 1 study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This protocol will determine the pK profile of two different omega-3 fatty acid supplements on plasma EPA and DHA levels.
Interventions
- DIETARY_SUPPLEMENT OM3-supplement 1
- DIETARY_SUPPLEMENT OM3-supplement 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03017651
The ClinicalTrials.gov registry entry for NCT03017651 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OM3-supplement 1 is the first listed.
NCT03017651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03017651 about?
NCT03017651 is a clinical study titled "An Evaluation of Omega-3 Fatty Acid". This protocol will determine the pK profile of two different omega-3 fatty acid supplements on plasma EPA and DHA levels.
What is the current status of trial NCT03017651?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2016-11. Estimated completion is 2017-05.
What interventions are being tested in trial NCT03017651?
The interventions under investigation include: OM3-supplement 1 (DIETARY_SUPPLEMENT), OM3-supplement 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03017651?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.